BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Chiesi Group

1 post
Oak Hill Bio and Chiesi Resume Phase 2b Clinical Study for OHB-607 to Treat Bronchopulmonary Dysplasia

Biotech NewsOak Hill Bio and Chiesi Resume Phase 2b Clinical Study for OHB-607 to Treat Bronchopulmonary Dysplasia

  • BioTech Health X
  • May 17, 2024
Oak Hill Bio and Chiesi Group have announced the enrollment of the first patient in a resumed Phase…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Verastem (VSTM) Isn’t “Small-Cap Roulette” Anymore—It’s a Commercial Oncology Ramp With a 2026 Twist
  • The Market Cap Is Small, the Idea Is Huge: Can Allogene (ALLO) Make CAR-T as Easy as Ordering a Drug?
  • 44% Real-World Response? Iovance (IOVA) Just Made “Off-the-Bench” Data the New Headline
  • Compass Therapeutics (CMPX) Has a “Survival Data” Trapdoor — And 2026 Might Be When It Opens
  • Nuvation (NUVB)’s “Quiet Launch” Isn’t Quiet Anymore: The Patient-Start Numbers That Got Biotech Watching
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • February 13, 2026
    Verastem (VSTM) Isn’t “Small-Cap Roulette” Anymore—It’s a Commercial Oncology Ramp With a 2026 Twist
    • February 13, 2026
    The Market Cap Is Small, the Idea Is Huge: Can Allogene (ALLO) Make CAR-T as Easy as Ordering a Drug?
    • February 13, 2026
    44% Real-World Response? Iovance (IOVA) Just Made “Off-the-Bench” Data the New Headline
    • February 13, 2026
    Compass Therapeutics (CMPX) Has a “Survival Data” Trapdoor — And 2026 Might Be When It Opens
    • February 13, 2026
    Nuvation (NUVB)’s “Quiet Launch” Isn’t Quiet Anymore: The Patient-Start Numbers That Got Biotech Watching
Recent Posts
  • Top 10 Cancer Biotech Small-Caps That Could Shock the Market Next
    • February 13, 2026
  • The “No Heart Damage” Cancer Drug Angle: Is Moleculin (MBRX)’s Annamycin the Plot Twist in AML?
    • February 12, 2026
  • Achieve Life Sciences (ACHV) Has a June 2026 “Make-or-Break” Date—Is This the Smoking Cessation Biotech Everyone’s Early On?
    • February 12, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (782)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top